Intensive Care Unit, Royal Adelaide Hospital.
School of Medicine, University of Adelaide, South Australia.
Curr Opin Crit Care. 2021 Apr 1;27(2):141-146. doi: 10.1097/MCC.0000000000000813.
Progress has been made in our understanding of gut dysfunction in critical illness. This review will outline new findings and give perspectives based on previous knowledge and concurrent advances in nutrition.
The relationship between gut dysfunction and poor outcomes in critical illness has received considerable interest. It remains uncertain whether gut dysfunction is merely a marker of illness severity or if it is directly responsible for prolonged critical illness and increased mortality. This relationship is difficult to ascertain given there is no agreed method for identification and quantification; biomarkers such as intestinal fatty acid binding protein and citrulline show promise but require further study. Recent studies have investigated strategies to deliver enteral nutrition targets with impacts on gut function, including high calorie or protein formulae, intermittent regimes and novel prokinetics.
Gut dysfunction is associated with poor outcomes, but it remains uncertain whether strategies to improve gut function will influence survival and recovery.
人们对危重病患者肠道功能障碍的认识已经取得了进展。本综述将概述新的发现,并基于既往知识和营养方面的最新进展提出观点。
肠道功能障碍与危重病患者预后不良之间的关系已引起广泛关注。目前仍不确定肠道功能障碍仅仅是疾病严重程度的标志物,还是其直接导致了危重病的延长和死亡率的增加。由于尚无公认的识别和定量方法,因此很难确定这种关系;肠道脂肪酸结合蛋白和瓜氨酸等生物标志物显示出一定的前景,但仍需要进一步研究。最近的研究探讨了实现肠道功能目标的策略,包括高热量或高蛋白配方、间歇性方案和新型促动力药物。
肠道功能障碍与不良预后相关,但改善肠道功能的策略是否会影响生存和恢复仍不确定。